Adjuvant Therapy | 2023 KU Breast Cancer Year in Review Conference

preview_player
Показать описание
In this session, Dr William Gradishar from Northwestern University Feinberg School of Medicine discusses strategies for optimizing adjuvant chemotherapy and endocrine therapy in patients with hormone receptor positive early breast cancer.
  1. Total Health | Oncology
Рекомендации по теме
Adjuvant Therapy | 0:30:22

Adjuvant Therapy | 2023 KU Breast Cancer Year in Review Conference

Adjuvant Therapy | 0:46:31

Adjuvant Therapy | 2023 Best of Breast Conference

Adjuvant Endocrine Therapy 0:02:47

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

2022 KU Post 0:23:20

2022 KU Post San Antonio Review | (Neo)adjuvant Therapy for Triple Negative Breast Cancer

On the Role 0:02:56

On the Role of Molecular Tumor Profiling in Breast Cancer: 2023 KU Breast Cancer Year in Review

Metastatic Hormone Positive 0:26:08

Metastatic Hormone Positive Breast Cancer | 2023 KU Breast Cancer Year in Review Conference

Adjuvant Treatment for 0:30:56

Adjuvant Treatment for Early Stage Hormone Positive Breast Cancer: Role of Genomic Signatures

Radiation After Lumpectomy 0:03:03

Radiation After Lumpectomy – Determining Who Benefits: 2023 KU Breast Cancer Year in Review

Adjuvant endocrine therapy 0:06:09

Adjuvant endocrine therapy for breast cancer: optimal durations and regimens

Historical Perspective on 0:05:19

Historical Perspective on HR+/HER2- Breast Cancer: 2023 KU Breast Cancer Year in Review

2022 KU Post 0:31:32

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic Therapy

The benefits and 0:01:07

The benefits and pitfalls of total neoadjuvant therapy in rectal cancer

Unmet needs and 0:02:06

Unmet needs and CDK4/6 inhibitors in HR+/HER2- early breast cancer

Neoadjuvant Endocrine Therapy 0:57:06

Neoadjuvant Endocrine Therapy in Breast Cancer

Adjuvant Abemaciclib/Ribociclib #monarchE/NATALEE 0:29:10

Adjuvant Abemaciclib/Ribociclib #monarchE/NATALEE #Best Treatment for Breast cancer #CDK 4/6 -Cure

Neoadjuvant vs. Adjuvant 0:22:25

Neoadjuvant vs. Adjuvant vs. None – “Perioperative Therapy”

TNBC Current and 1:08:58

TNBC Current and Emerging Therapeutic Strategies | 2023 Best of Breast Conference

What to look 0:03:24

What to look forward to in breast cancer at ASCO 2023

HER2 Low Breast 0:25:20

HER2 Low Breast Cancer A New Therapeutic Subtype | 2023 KU Breast Cancer Year in Review Conference

Durvalumab and PET-directed 0:01:50

Durvalumab and PET-directed chemoradiation in advanced esophageal cancer

Lightning Updates | 0:20:55

Lightning Updates | 2023 Best of Breast Conference

Adjuvant Endocrine Therapy 0:48:22

Adjuvant Endocrine Therapy for high-risk breast cancer

Updates in Systemic 0:43:14

Updates in Systemic Therapy for Breast Cancer 2/8/23

Patients with High 0:53:17

Patients with High Risk Features | 2023 Best of Breast Conference